Status:
COMPLETED
Vaccination In Pregnancy Gene Signature: VIP Signature Study
Lead Sponsor:
St George's, University of London
Collaborating Sponsors:
Innovative Medicine Initiative
Max Planck Institute for Infection Biology
Conditions:
Pregnancy Related
Vaccination
Eligibility:
FEMALE
Brief Summary
A study investigating gene expression profiles in pregnant women in response to a pertussis containing vaccination in pregnancy.
Detailed Description
Vaccinations are a vital part of ensuring population health, but there is a continued need for new and improved vaccines to be developed and this process of design and development can be both slow and...
Eligibility Criteria
Inclusion
- Pregnant at a gestation of 16-32 weeks
- No contraindications to vaccination according to the green book
- No known immunodeficiency
- Able to understand the details of the study and willing to provide informed consent
Exclusion
- Having received a pertussis containing vaccine within the last 12 months
- Contraindications to vaccination according to the green book
Key Trial Info
Start Date :
September 7 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 21 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03284515
Start Date
September 7 2017
End Date
March 21 2018
Last Update
January 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St George's, University of London
London, United Kingdom, SW170RE